Liver Cancer Stage D (Terminal, BCLC-D)

What Stage D (Terminal, BCLC-D) Means

PS ≥2, advanced disease with marked liver dysfunction

Treatment Approach for Stage D (Terminal, BCLC-D)

Best supportive care, palliative care focus. Consider clinical trials if eligible.

Survival Rates and Prognosis

The 5-year survival rate for liver cancer at Stage D (Terminal, BCLC-D) is approximately 5-year: <5%. Survival rates are statistical averages drawn from large patient populations and may not reflect your individual outcome. Factors that influence your specific prognosis include your age, overall health, tumour biology, and how well the cancer responds to treatment.

Important: These numbers are drawn from historical data. Newer treatments available today may improve outcomes beyond what published statistics show. Discuss your individual prognosis with your oncologist.

How Other Stages Compare

Stage	5-Year Survival	Treatment
Stage 0 (Very early, BCLC-0)	5-year: 70–80%	Resection, ablation (RFA/MWA), or transplant. Adjuvant therapy per protocol….
Stage A (Early, BCLC-A)	5-year: 50–70%	Resection, ablation, TACE, or transplant. Consider adjuvant therapy. Curative…
Stage B (Intermediate, BCLC-B)	5-year: 30–50%	TACE, sequential TACE + sorafenib. Lenvatinib emerging option. Consider…
Stage C (Advanced, BCLC-C)	5-year: 10–20%	Sorafenib, lenvatinib, atezolizumab+bevacizumab. Clinical trials. Immunotherapy…